178 related articles for article (PubMed ID: 28146011)
1. PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.
Fohner AE; Sparreboom A; Altman RB; Klein TE
Pharmacogenet Genomics; 2017 Apr; 27(4):164-167. PubMed ID: 28146011
[No Abstract] [Full Text] [Related]
2. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.
Zuckerman JM
Infect Dis Clin North Am; 2004 Sep; 18(3):621-49, xi-. PubMed ID: 15308279
[TBL] [Abstract][Full Text] [Related]
3. The newer macrolides: azithromycin and clarithromycin.
Zuckerman JM
Infect Dis Clin North Am; 2000 Jun; 14(2):449-62, x. PubMed ID: 10829265
[TBL] [Abstract][Full Text] [Related]
4. [New therapeutic uses of the macrolides].
Mihălţan F
Pneumologia; 2004; 53(3):100-4. PubMed ID: 16108157
[No Abstract] [Full Text] [Related]
5. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
6. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Shimizu T; Suzaki H
Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
[TBL] [Abstract][Full Text] [Related]
7. Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
Zuckerman JM; Qamar F; Bono BR
Infect Dis Clin North Am; 2009 Dec; 23(4):997-1026, ix-x. PubMed ID: 19909895
[TBL] [Abstract][Full Text] [Related]
8. The macrolides: erythromycin, clarithromycin, and azithromycin.
Alvarez-Elcoro S; Enzler MJ
Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Hoban DJ; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
[TBL] [Abstract][Full Text] [Related]
10. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Simoens S; Laekeman G; Decramer M
Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
[TBL] [Abstract][Full Text] [Related]
11. Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006).
Glass SK; Pearl DL; McEwen SA; Finley R
J Antimicrob Chemother; 2010 Jan; 65(1):148-55. PubMed ID: 19864333
[TBL] [Abstract][Full Text] [Related]
12. Macrolides in dermatology.
Scheinfeld NS; Tutrone WD; Torres O; Weinberg JM
Clin Dermatol; 2003; 21(1):40-9. PubMed ID: 12609587
[No Abstract] [Full Text] [Related]
13. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
14. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
15. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
Nagai K; Davies TA; Ednie LM; Bryskier A; Palavecino E; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391
[TBL] [Abstract][Full Text] [Related]
16. Macrolides use and the risk of sudden cardiac death.
Li X; Wang M; Liu G; Zhou L; Wang Z; Li C
Expert Rev Anti Infect Ther; 2016 Jun; 14(6):535-7. PubMed ID: 27086751
[No Abstract] [Full Text] [Related]
17. Macrolides for acute lung injury.
Noto MJ; Wheeler AP
Chest; 2012 May; 141(5):1131-1132. PubMed ID: 22553255
[No Abstract] [Full Text] [Related]
18. Macrolide antibiotic therapy in patients with cystic fibrosis.
Schöni MH
Swiss Med Wkly; 2003 May; 133(21-22):297-301. PubMed ID: 12861467
[TBL] [Abstract][Full Text] [Related]
19. Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Siekmeier R; Hofmann T; Scheuch G
Adv Exp Med Biol; 2015; 839():13-24. PubMed ID: 25252902
[TBL] [Abstract][Full Text] [Related]
20. The newer macrolides. Azithromycin and clarithromycin.
Zuckerman JM; Kaye KM
Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
